Chemoprevention in breast cancer and possible vaccine for prostate cancer

Response to rituximab induction is a predictive biomarker in post-transplant lymphoproliferative disorder

“Low but real” risk of myelodysplastic syndromes caused by thyroid cancer treatment

High dose chemotherapy plus transplant remains standard care for young newly diagnosed multiple myeloma patients

ENDEAVOR: carfilzomib new standard in multiple myeloma?

How can functional drug screening guide personalised cancer therapy?

How do genes influence the development of chronic idiopathic thrombocytopenic purpura?

Combining treatment options for higher risk myelodysplastic syndromes and chronic myelomonocytic leukaemia

Incidence of and predictors for early death in paediatric patients with acute promyelocytic leukaemia

Blinatumomab has promising effect on hard-to-treat, rare acute lymphoblastic leukaemia subtype

Rituximab plus chemotherapy improves outcomes in acute lymphoblastic leukaemia

First all-oral treatment for relapsed and treatment-resistant multiple myeloma